Lower-risk Myelodysplastic Syndromes: Data Updates and Evolving Treatment Paradigms in the Frontline Setting : Episode 1
Risk Stratification of Myelodysplastic Syndromes [MDS]
Ralph Boccia, MD, FACP, and Hetty Carraway, MD, review Myelodysplastic Syndromes [MDS] risk stratification criteria used in their practices.
Now Viewing
EP: 1.Risk Stratification of Myelodysplastic Syndromes [MDS]
EP: 2.Importance of Early Diagnosis of MDS for Lower and Higher-risk Patients
EP: 3.Frontline Treatment Options for Lower-Risk MDS
EP: 4.Clinical Use of Luspatercept on Patients with Lower-risk MDS
EP: 5.Safety and Efficacy of Luspatercept in Frontline Setting in Patients with MDS
EP: 6.Emerging Therapies for Treatment of MDS
EP: 7.Clinical Management of Patients with Lower-risk MDS
EP: 8.Unmet Needs and Future Perspectives in Treatment of MDS
Related Videos
Related Content
